Skip to content
Literatúra
- Raj CD, et al. Terminalia arjuna’s antioxidant effect in isolated perfused kidney. Res Pharm Sci. (2012)
- Dwivedi S. Terminalia arjuna Wight & Arn.–a useful drug for cardiovascular disorders. J Ethnopharmacol. (2007)
- Mahmood ZA, et al. Herbal treatment for cardiovascular disease the evidence based therapy. Pak J Pharm Sci. (2010)
- Maulik SK, Katiyar CK. Terminalia arjuna in cardiovascular diseases: making the transition from traditional to modern medicine in India. Curr Pharm Biotechnol. (2010)
- Miller AL. Botanical influences on cardiovascular disease. Altern Med Rev. (1998)
- Scassellati-Sforzolini G, et al. Antigenotoxic properties of Terminalia arjuna bark extracts. J Environ Pathol Toxicol Oncol. (1999)
- Verma SC, et al. Microwave extraction and rapid isolation of arjunic acid from Terminalia arjuna (Roxb. ex DC.) stem bark and quantification of arjunic acid and arjunolic acid using HPLC-PDA technique. J Sep Sci. (2012)
- Sarwat M, Das S, Srivastava PS. Estimation of genetic diversity and evaluation of relatedness through molecular markers among medicinally important trees: Terminalia arjuna, T. chebula and T. bellerica. Mol Biol Rep. (2011)
- Biswas M, et al. Antitumour activity of Terminalia arjuna leaf against Ehrlich ascites carcinoma in mice. Nat Prod Res. (2012)
- [No authors listed. Terminalia arjuna. Altern Med Rev. (1999)
- The chemistry of extractives from hardwoods. Part XVIII. The constitution of arjunolic acid, a triterpene from Terminalia arjuna.
- Saxena M, et al. Cytotoxic agents from Terminalia arjuna. Planta Med. (2007)
- Singh DV, et al. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal. (2002)
- Wang W, et al. 18,19-secooleanane type triterpene glycosyl esters from the bark of Terminalia arjuna. Planta Med. (2010)
- Upadhyay RK, et al. Triterpene glycoside from Terminalia arjuna. J Asian Nat Prod Res. (2001)
- Wang W, et al. Triterpenoids from two Terminalia species. Planta Med. (2010)
- Ali A, et al. A novel naphthanol glycoside from Terminalia arjuna with antioxidant and nitric oxide inhibitory activities. Pharmazie. (2003)
- Alam MS, et al. Two new bioactive oleanane triterpene glycosides from Terminalia arjuna. Nat Prod Res. (2008)
- Ali A, et al. Terminoside A, a new triterpene glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages. J Asian Nat Prod Res. (2003)
- Singh B, et al. A new triterpene glycoside from Terminalia arjuna. Planta Med. (1995)
- Dwivedi S, Aggarwal A. Indigenous drugs in ischemic heart disease in patients with diabetes. J Altern Complement Med. (2009)
- Yadav RN, Rathore K. A new cardenolide from the roots of Terminalia arjuna. Fitoterapia. (2001)
- Yadava RN, Rathore K. A new cardenolide from the seeds of Terminalia arjuna (W&A). J Asian Nat Prod Res. (2000)
- Wang W, et al. Ursane triterpenoids from the bark of Terminalia arjuna. Fitoterapia. (2010)
- Oberoi L, et al. The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes. Phytomedicine. (2011)
- Kuo PL, et al. Casuarinin from the bark of Terminalia arjuna induces apoptosis and cell cycle arrest in human breast adenocarcinoma MCF-7 cells. Planta Med. (2005)
- Kandil FE, Nassar MI. A tannin anti-cancer promotor from Terminalia arjuna. Phytochemistry. (1998)
- Avula B, et al. Simultaneous Determination and Characterization of Tannins and Triterpene Saponins from the Fruits of Various Species of Terminalia and Phyllantus emblica Using a UHPLC-UV-MS Method: Application to Triphala. Planta Med. (2013)
- Khaliq F, et al. Terminalia arjuna Improves Cardiovascular Autonomic Neuropathy in Streptozotocin-Induced Diabetic Rats. Cardiovasc Toxicol. (2013)
- Dall’Ago P, et al. Baroreflex and chemoreflex dysfunction in streptozotocin-diabetic rats. Braz J Med Biol Res. (1997)
- Parveen A, et al. Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure rats. J Cardiovasc Pharmacol Ther. (2012)
- Parveen A, et al. Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats. Cardiovasc Toxicol. (2011)
- Kumar S, et al. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J Pharm Pharmacol. (2009)
- Sinha M, Manna P, Sil PC. Terminalia arjuna protects mouse hearts against sodium fluoride-induced oxidative stress. J Med Food. (2008)
- Singh G, et al. Protective effects of Terminalia arjuna against Doxorubicin-induced cardiotoxicity. J Ethnopharmacol. (2008)
- Karthikeyan K, et al. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sci. (2003)
- Gauthaman K, et al. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein. J Ethnopharmacol. (2005)
- Manna P, Sinha M, Sil PC. Phytomedicinal activity of Terminalia arjuna against carbon tetrachloride induced cardiac oxidative stress. Pathophysiology. (2007)
- Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J. (1997)
- Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. Ann Intern Med. (1992)
- Ischemic mitral regurgitation: mechanisms and echocardiographic classification.
- Dwivedi S, et al. Role of Terminalia arjuna in ischaemic mitral regurgitation. Int J Cardiol. (2005)
- Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol. (1995)
- Bharani A, et al. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J. (2002)
- Dwivedi S, Kumar V. Beta-thalassemia, hyperlipoproteinemia(a), and metabolic syndrome: its low-cost holistic therapy. J Altern Complement Med. (2007)
- Subramaniam S, et al. Anti-Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits. Evid Based Complement Alternat Med. (2011)
- Subramaniam S, et al. Anti-hyperlipidemic and antioxidant potential of different fractions of Terminalia arjuna Roxb. bark against PX- 407 induced hyperlipidemia. Indian J Exp Biol. (2011)
- Johnston TP, Palmer WK. Mechanism of poloxamer 407-induced hypertriglyceridemia in the rat. Biochem Pharmacol. (1993)
- Chander R, et al. Antidyslipidemic and antioxidant activities of different fractions ofTerminalia arjuna stem bark. Indian J Clin Biochem. (2004)
- Bharani A, Ahirwar LK, Jain N. Terminalia arjuna reverses impaired endothelial function in chronic smokers. Indian Heart J. (2004)
- Saha S, Verma R. Inhibitory potential of traditional herbs on α-amylase activity. Pharm Biol. (2012)
- Biswas M, et al. Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats. Pharm Biol. (2011)
- Sandhu JS, et al. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. Int J Ayurveda Res. (2010)
- Parmar HS, et al. Cardio-protective role of Terminalia arjuna bark extract is possibly mediated through alterations in thyroid hormones. Pharmazie. (2006)
- Watanabe H, et al. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun. (2003)
- Donatelli M, et al. Cardiac changes in subclinical and overt hyperthyroid women: retrospective study. Int J Cardiol. (2003)
- Devi RS, et al. Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide-induced gastric ulcer in rats. J Pharm Pharmacol. (2008)
- Devi RS, et al. Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental rats. Phytother Res. (2007)
- Devi RS, et al. Gastroprotective effect of Terminalia arjuna bark on diclofenac sodium induced gastric ulcer. Chem Biol Interact. (2007)
- Aneja KR, Sharma C, Joshi R. Antimicrobial activity of Terminalia arjuna Wight & Arn.: an ethnomedicinal plant against pathogens causing ear infection. Braz J Otorhinolaryngol. (2012)
- Shivananjappa MM, Mhasavade D, Joshi MK. Aqueous extract of Terminalia arjuna attenuates tert-butyl hydroperoxide-induced oxidative stress in HepG2 cell model. Cell Biochem Funct. (2012)
- Manna P, Sinha M, Sil PC. Aqueous extract of Terminalia arjuna prevents carbon tetrachloride induced hepatic and renal disorders. BMC Complement Altern Med. (2006)
- Ragavan B, Krishnakumari S. Effect of terminalia arjuna stem bark extract on the activities of marker enzymes in alloxan induced diabetic rats. Anc Sci Life. (2005)
- Raghavan B, Kumari SK. Effect of Terminalia arjuna stem bark on antioxidant status in liver and kidney of alloxan diabetic rats. Indian J Physiol Pharmacol. (2006)
- Chen CH, et al. Casuarinin protects cultured MDCK cells from hydrogen peroxide-induced oxidative stress and DNA oxidative damage. Planta Med. (2004)
- Chaudhary A, Singla SK, Tandon C. In vitro Evaluation of Terminalia arjuna on Calcium Phosphate and Calcium Oxalate Crystallization. Indian J Pharm Sci. (2010)
- Manna P, Sinha M, Sil PC. Protection of arsenic-induced testicular oxidative stress by arjunolic acid. Redox Rep. (2008)
- Pawar RS, Bhutani KK. Effect of oleanane triterpenoids from Terminalia arjuna–a cardioprotective drug on the process of respiratory oxyburst. Phytomedicine. (2005)
- Sun FY, et al. Arjunic acid, a strong free radical scavenger from Terminalia arjuna. Am J Chin Med. (2008)
- Reddy TK, et al. Effect of Terminalia arjuna extract on adriamycin-induced DNA damage. Phytother Res. (2008)
- Pal S, et al. Involvement of both intrinsic and extrinsic pathways in hepatoprotection of arjunolic acid against cadmium induced acute damage in vitro. Toxicology. (2011)
- Manna P, et al. Arjunolic acid, a triterpenoid saponin, ameliorates arsenic-induced cyto-toxicity in hepatocytes. Chem Biol Interact. (2007)
- Kaur K, et al. Antimutagenic activities of acetone and methanol fractions of Terminalia arjuna. Food Chem Toxicol. (2002)
- Gangadevi V, Muthumary J. A novel endophytic Taxol-producing fungus Chaetomella raphigera isolated from a medicinal plant, Terminalia arjuna. Appl Biochem Biotechnol. (2009)
- Gangadevi V, Muthumary J. Taxol production by Pestalotiopsis terminaliae, an endophytic fungus of Terminalia arjuna (arjun tree). Biotechnol Appl Biochem. (2009)
- Ehrlich ascites carcinoma.
- Ramesh AS, et al. Isolation, characterisation and cytotoxicity study of arjunolic acid from Terminalia arjuna. Nat Prod Res. (2012)
- Ganesan R, Kamalraj P, Muthuchelian K. Protective effects of ethanolic extract residue isolated from the bark of Terminalia Arjuna against DLA tumour cells. Asian Pac J Cancer Prev. (2010)
- Verma N, Vinayak M. Effect of Terminalia arjuna on antioxidant defense system in cancer. Mol Biol Rep. (2009)
- Dhanarasu S, et al. Terminalia Arjuna (Roxb.) Modulates Circulatory Antioxidants on 7,12-dimethylbenz(a)anthracene- induced Hamster Buccal Pouch Carcinogenesis. Oman Med J. (2010)
- Kuo PL, et al. Induction of cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells by casuarinin from the bark of Terminalia arjuna Linn. Anticancer Drugs. (2005)
- Sivalokanathan S, Vijayababu MR, Balasubramanian MP. Effects of Terminalia arjuna bark extract on apoptosis of human hepatoma cell line HepG2. World J Gastroenterol. (2006)
- Sivalokanathan S, Ilayaraja M, Balasubramanian MP. Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol Cell Biochem. (2006)
- Sivalokanathan S, Ilayaraja M, Balasubramanian MP. Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Indian J Exp Biol. (2005)